Distribution of the iron-regulating protein hepcidin in the murine central nervous system

Journal of Neuroscience Research

Volumn 84, Issue 4, 2006, Pages 790-800

  Zechel, S ^a   Huber Wittmer, K ^a   Von Halbach, Oliver Bohlen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antimicrobial peptide; Brain; Expression; Mouse; Neuron; Spinal cord

Indexed keywords

HEPCIDIN;

AMINO ACID SEQUENCE; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33748569185     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20991     Document Type: Article

References (34)

1. Berg D, Hoggenmuller U, Hofmann E, Fischer R, Kraus M, Scheurlen M, Becker G. 2000. The basal ganglia in hemochromatosis. Neuroradiology 42:9-13.
2. Bridle K. 2003. Disrupted hepcidin regulation in HFE associated hemochromatosis and the liver as a regulator of body iron homeostasis. Lancet 361:669-673.
3. Bush AI. 2000. Metals and neuroscience. Curr Opin Chem Biol 4:184-191.
4. Connor JR, Menzies SL. 1996. Relationship of iron to oligodendrocytes and myelination. Glia 17:83-93.
5. Costello DJ, Walsh SL, Harrington HJ, Walsh CH. 2004. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series. J Neurol Neurosurg Psychiatry 75:631-633.
6. Dekker MCJ, Giesbergen PC, Njajou OT, van Swieten JC, Hofman A, Breteler MMB, van Duijn CM. 2003. Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism. Neurosci Lett 348:117-119.
7. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. New York: Academic Press.
8. Ganz T. 2003. Hepcidin as a regulator of iron metabolism and mediator of anemia and inflammation. Blood 102:783-788.
9. Good PF, Olanow CW, Perl DP. 1992. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Res 593:343-346.
10. Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O, Morrison KE. 2005. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology 65:934-937.
11. Halliwell B. 1987. Oxidants and human disease: some new concepts. FASEB J 1:358-364.
12. Ilyin G, Courselaud B, Troadec MB, Pigeon C, Alizadeh M, Leroyer P, Brissot P, Loreal O. 2003. Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different pattern of expression and coinducebility during iron overload. FEES Lett 542:22-26.
13. Jiang DH, Ke Y, Cheng YZ, Ho KP, Qian ZM. 2002. Distribution of ferroportinl protein in different regions of developing rat brain. Dev Neurosci 24:94-98.
14. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W. 2004. Prohepcidin: expression and cell specific localization in the liver and its regulation in hereditary hemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 53:735-743.
15. Lee P, Peng H, Gelbart T, Beutler E. 2004. The IL-6- and lipopolysaccharide-induce transcription of hepcidin in HFE-, transferrin receptor 2-, and β2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 101:9263-9265.
16. Lou DQ, Nicolas G, Lesbordes JC, Viatte L, Szajnert MF, Kahn A, Vaulont S. 2004. Functional differences between hepcidin 1 and 2 in transgenic mice. Blood 103:2816-2821.
17. Leibold E, Gahring L, Rogers S. 2001. Immunolocalization of iron regulatory protein expression in the murine central nervous system. Histochem Cell Biol 115:195-203.
18. Lozoff B, Jimenez E, Wolf A. 1991. Long-term developmental outcome of infants with iron deficiency. N Engl J Med 325:687-694.
19. Moalem S, Percy ME, Andrews DF, Kruck TP, Wong S, Dalton AJ, Mehta P, Fedor B, Warren AC. 2000. Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 93:58-66.
20. Moos T. 1996. Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J Comp Neurol 375:675-692.
21. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DMV, Ganz T, Kaplan J. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-2093.
22. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S. 2001. Lack of hepcidin expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 98:8780-8785.
23. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, Sirito M, Swadogo M, Kahn A, Vaulont S. 2002a. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 99:4596-4601.
24. Nicolas G, Chauvet C, Viatte L, Donan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. 2002b. The gene encoding the iron regulatory protein hepcidin is regulated by anemia, hypoxia and inflammation. J Clin Invest 110:1037-1044.
25. Park C, Valore E, Waring A, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276:7806-7810.
26. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. 2001. A new mouse liver-specific gene, encoded a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811-7819.
27. Qian M, Wang Q. 1998. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Rev 27:257-267.
28. Roetto A. 2003. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21-22.
29. Rossi E. 2005. Hepcidin-the iron regulatory hormone. Clin Biochem Rev 26:47-49.
30. Wang RH, Li C, Xu X, Zheng Y, Xiao C, Zerfas P, Cooperman S, Eckhaus M, Rouault T, Mishra L, Deng CX. 2005. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2:399-409.
31. Wang XS, Lee S, Simmons Z, Boyer P, Scott K, Liu W, Connor J. 2004. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci 227:27-33.
32. Wrigglesworth JM, Baum H. 1988. Iron dependent enzymes in the brain. In: Youdium MBH, ed. Brain iron: neurochemical and behavioral aspects. New York: Taylor and Francis, p 25-66.
33. Wu LJ, Leenders AG, Cooperman S, Meyron-Holtz E, Smith S, Land W, Tsai RY, Berger UV, Sheng ZH, Rouault TA. 2004. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res 1001:108-117.
34. Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR. 2004. Iron, brain aging and neurodegenerative disorders. Nat Rev Neurosci 5:863-873.